Owkin Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 472

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 20

Owkin General Information

Description

Developer of machine learning tools designed to augment medical and biological research. The company's platform understands complex biology through AI, identifies new treatments, de-risk, and accelerates clinical trials to inform drug discovery, de-risk clinical trials, and develop and deploy diagnostics, enabling pharmaceutical companies to understand drug efficacy variation, to improve the drug development process, and improve treatment outcomes.

Contact Information

Website
www.owkin.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 110 East 25th Street
  • New York, NY 10010
  • United States
Primary Industry
Enterprise Systems (Healthcare)
Other Industries
Biotechnology
Drug Discovery
Vertical(s)
Digital Health, Artificial Intelligence & Machine Learning, Oncology
Corporate Office
  • 110 East 25th Street
  • New York, NY 10010
  • United States

Owkin Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Owkin Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Later Stage VC 31-Dec-2024 Completed Generating Revenue
8. Later Stage VC (Series B1) 09-Jun-2022 Completed Generating Revenue
7. Later Stage VC (Series B) 18-Nov-2021 Completed Generating Revenue
6. Early Stage VC (Series A3) 06-May-2020 Completed Generating Revenue
5. Early Stage VC (Series A2) 07-Mar-2019 Completed Generating Revenue
4. Early Stage VC (Series A) 23-May-2018 Completed Generating Revenue
3. Accelerator/Incubator 20-Mar-2018 Completed Generating Revenue
2. Accelerator/Incubator 02-Nov-2017 $2.1M Completed Generating Revenue
1. Seed Round 01-Oct-2016 $2.1M $2.1M Completed Startup
To view Owkin’s complete valuation and funding history, request access »

Owkin Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series B
Series A3
Series A2
Series A 5,936,265 $0.000100 $2.7 $2.7 1x $2.7 19.96%
Seed 3,589,861 $0.000100 $0.59 $0.59 1x $0.59 12.07%
To view Owkin’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Owkin Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of machine learning tools designed to augment medical and biological research. The company's platform understa
Enterprise Systems (Healthcare)
New York, NY
472 As of 2025

South San Francisco, CA
 

Nottingham, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Owkin Competitors (18)

One of Owkin’s 18 competitors is Verge Genomics, a Venture Capital-Backed company based in South San Francisco, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Verge Genomics Venture Capital-Backed South San Francisco, CA
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
X-37 Venture Capital-Backed South San Francisco, CA
OrphAI Therapeutics Venture Capital-Backed New Haven, CT
NuMedii Venture Capital-Backed San Mateo, CA
You’re viewing 5 of 18 competitors. Get the full list »

Owkin Patents

  • 33

    Total Documents Applications and Grants

  • Total Patents Families

  • 16

    Granted

  • 17

    Pending

  • Expiring in next 12 mo

Owkin Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4487337-A1 Systems and methods for designing randomized controlled studies Pending 04-Mar-2022
US-20230282362-A1 Systems and methods for determining breast cancer prognosis and associated features Pending 16-Sep-2021
EP-4205143-A1 Systems and methods for determining breast cancer prognosis and associated features Pending 16-Sep-2021
US-20240112812-A1 Systems and methods for determining breast cancer prognosis and associated features Pending 16-Sep-2021
AU-2022345851-A1 Systems and methods for determining breast cancer prognosis and associated features Pending 16-Sep-2021 G16H30/40
To view Owkin’s complete patent history, request access »

Owkin Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Owkin Investors (20)

Investor Name Investor Type Holding Investor Since Participating Rounds
Bristol-Myers Squibb Corporation Minority
Key Ventures Venture Capital Minority
Sanofi Corporation Minority
Bpifrance Sovereign Wealth Fund Minority
Groupe MACSF Impact Investing Minority
You’re viewing 5 of 20 investors. Get the full list »

Owkin Investments (2)

Owkin’s most recent deal was a Early Stage VC with Bioptimus for . The deal was made on 19-Feb-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bioptimus 19-Feb-2024 Early Stage VC Biotechnology
Tribun Health 01-Dec-2022 Later Stage VC Diagnostic Equipment
To view Owkin’s complete investments history, request access »

Ready to get started?

Request a free trial

Owkin FAQs

  • When was Owkin founded?

    Owkin was founded in 2016.

  • Where is Owkin headquartered?

    Owkin is headquartered in New York, NY.

  • What is the size of Owkin?

    Owkin has 472 total employees.

  • What industry is Owkin in?

    Owkin’s primary industry is Enterprise Systems (Healthcare).

  • Is Owkin a private or public company?

    Owkin is a Private company.

  • What is Owkin’s current revenue?

    The current revenue for Owkin is .

  • How much funding has Owkin raised over time?

    Owkin has raised $334M.

  • Who are Owkin’s investors?

    Bristol-Myers Squibb, Key Ventures, Sanofi, Bpifrance, and Groupe MACSF are 5 of 20 investors who have invested in Owkin.

  • Who are Owkin’s competitors?

    Verge Genomics, Sygnature Discovery, X-37, OrphAI Therapeutics, and NuMedii are some of the 18 competitors of Owkin.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »